Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic Advances Its Data Logic Division with New Staff Appointments


BERKELEY, Calif.--Gene Logic filled two key positions last month in its newly expanded and named Data Logic division here. The company also said it has expanded the division's mission to market its suite of data-management and integration tools directly to pharmaceutical companies. The division already develops and deploys Gene Logic's proprietary and custom-built databases for pharmaceutical company partners.

Gene Logic bioinformatics tools are based on the object protocol initially developed by Victor Markowitz at Lawrence Berkeley National Laboratory. Markowitz, who joined Gene Logic last year as vice-president of bioinformatics systems, has been promoted to senior vice-president of Data Logic. In the other appointment, Jim Veitch, formerly of Franz, a supplier of dynamic object-oriented development tools to the computer industry, was named vice-president of business development for the Data Logic Division.

Michael Brennan, Gene Logic's president, said he believes there is a "substantial, independent business opportunity" in the "growing market for comprehensive data management solutions for bioinformatics."

Filed under

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.